Cookie Policy         The Babraham Research Campus is also home to The Babraham Institute


  Babraham Bioscience Technologies
        Babraham Research Campus - Cambridge - UK
 

News
  2017
  2016
  2015
  2014
  2013
  2012
  2011
  2010
  2009
  2008
  2007

Video Library

Events

Press Releases and Media Reports 2017

 

Sphere Fluidics

Sphere Fluidics Limited and Partners Win Major InnovateUK Grant to Develop the World's First Desktop Genome Editing System. More...

17th July 2017

 

Abzena

Abzena : OBI Pharma signs agreement with Abzena for ADC linker technology. More...

15th July 2017

 

More ‘Killers’ on the loose in Cambridge Science and Tech cluster. More...

26th June 2017

 

Touchstone Innovations

Touchstone Invests GBP3.0 Million In Concirrus For 67% Stake. More...

19th June 2017

 

Kymab

Anbtibodies powerhouse Kymab has appointed immunologist Dr Sonia Quaratino as its first chief medical officer. Dr Quaratino (pictured) will manage the clinical development of the group’s expanding therapeutic antibody portfolio. More...

15th June 2017

 

Artios Pharma

Arix Bioscience plc (LSE: ARIX) (“Arix Bioscience” or the “Company”), a global healthcare and life science company supporting medical innovation, is pleased to note the announcement by Artios Pharma Ltd, an Arix Bioscience Group Business, that it has signed a research collaboration and option agreement with Masaryk University (“MU”) in the Czech Republic for the development of novel cancer treatments targeting DNA nucleases involved in the DNA damage response (DDR). More...

12th June 2017

 

F-star

F-star tees up potential €1bn antibodies windfall from Merck. More...

4th June 2017

 

F-Star

F-star Expands its Relationship with Merck through a new Strategic Collaboration to Develop Bispecific Antibodies in Immuno-Oncology. More...

4th June 2017

 

Bicycle Therapeutics

Bicycle Therapeutics Closes £40 Million ($52 Million) in Series B Financing to Advance Clinical Pipeline. More...

1st June 2017

 

Babraham Bioscience Technologies

Annual Babraham Investor Conference attracts over 120 investors focused on early-stage and scale-up life science and med-tech companies. More...

25th May 2017

 

Nemesis Bioscience

Nemesis Bioscience Closes Funding Round and Begins Preclinical Programmes. More...

8th May 2017

 

Bicycle Therapeutics

Bicycle Therapeutics Announces a Candidate Preclinical Milestone in Its Ophthalmology Alliance with ThromboGenics. More...

20th April 2017

 

Babraham Bioscience Technologies Limited

Biomed realty invests in the construction of labratory and office facilities at the Babraham Research Campus. More...

19th April 2017

 

Bicycle Therapeutics

Bicycle Therapeutics is Named Winner of Business Weekly’s Disruptive Technology Award 2017. More...

29th March 2017

 

Bicycle Therapeutics

Bicycle Therapeutics to Present at Cowen and Company 37th Annual Health Care Conference. More...

2nd March 2017

 

Storm Therapeutics

Storm Therapeutics announces appointment of CEO and Chairman. More...

24th February 2017

 

Rapid Biosensor Systems

SPIE Prism Award for Innovation in Biomedical Instrumentation and the winner is…The TB Breathalyser. More...

14th February 2017

 

SuperX

SuperX completes $11m investment for anticoagulant antibodies. More...

9th February 2017

 

Kymab

Kymab receives $9m grant from the Bill & Melinda Gates Foundation. More...

9th January 2017

 

Bicycle Therapeutics

Bicycle Therapeutics Appoints Nicholas Keen, Ph.D., as Chief Scientific Officer. More...

5th January 2017

 

 

 

Babraham Bioscience Technologies Ltd - Cambridge - United Kingdom